Wilmington, DE, United States of America

Keith Russell


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Newark, DE (US) (2002)
  • Wilmington, DE (US) (2002 - 2007)

Company Filing History:


Years Active: 2002-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Keith Russell

Introduction

Keith Russell is a notable inventor based in Wilmington, DE (US), recognized for his significant contributions to the field of medicinal chemistry. He holds a total of 4 patents, showcasing his dedication to advancing medical science and improving therapeutic options.

Latest Patents

Among his latest patents, Russell has developed neurokinin antagonists for use as medicaments. These compounds are designed to antagonize the pharmacological actions of the neurokinin 1 (NK) receptor. They are particularly useful in treating a variety of diseases where Substance P is involved, including major depressive disorder, severe anxiety disorders, and several other conditions such as obesity, rheumatoid arthritis, and Alzheimer's disease.

Career Highlights

Russell is currently employed at AstraZeneca AB, where he continues to innovate and contribute to the development of new therapeutic agents. His work focuses on creating compounds that can effectively address complex medical conditions, thereby enhancing patient care and treatment outcomes.

Collaborations

Throughout his career, Russell has collaborated with esteemed colleagues, including Peter Robert Bernstein and Cyrus Ohnmacht. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medicinal research.

Conclusion

Keith Russell's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for new treatments that can significantly impact patient health and well-being.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…